HIV 1 News and Research

RSS

Surveys reveal exceptional progress against HIV in Africa

National surveys in Zimbabwe, Malawi, and Zambia reveal exceptional progress against HIV, with decreasing rates of new infection, stable numbers of people living with HIV, and more than half of all those living with HIV showing viral suppression through use of antiretroviral medication. For those on antiretroviral medication, viral suppression is close to 90 percent.

2 Dec 2016

Special article outlines recommended strategies to prevent Zika from blood transfusion

As the Zika epidemic spreads to the United States, the potential for contracting the disease via blood transfusion has emerged as a serious concern.

2 Dec 2016

Researcher to study ethical complexities of involving teens at high risk for HIV in prevention trials

An Indiana University nursing researcher has been awarded $1.1 million to study the ethical complexities of involving adolescents ages 14-17 at high risk for HIV in biomedical prevention trials.

2 Dec 2016

New UGA research finds pathogen's motility activates immune response

Until now, a pathogen's ability to move through the body has been overlooked as a possible trigger of immune response, but new research from the University of Georgia College of Veterinary Medicine found that motility will indeed alarm the host and activate an immune response.

1 Dec 2016

‘Nudges’ could be effective way for encouraging patients to complete health care programs

Keeping messages brief and simple can produce gains when trying to encourage patients to complete a health care program, says research co-written by a University of Illinois expert in social psychology.

1 Dec 2016

New device could revolutionize drug delivery to treat cancer and other diseases, study shows

A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio, describes a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments.

1 Dec 2016

Liverpool-led research consortium aims to reduce mother-to-child transmission of HIV

Researchers from the University of Liverpool's Institute of Translational Medicine have been awarded a grant of up to US$ 8.9 million (GBP £5.8m) to lead a multinational research consortium that aims to reduce mother-to-child transmission of HIV.

1 Dec 2016

FIRS calls on governments, health organizations to strengthen response to HIV on World AIDS Day

In recognition of World AIDS Day, held annually on Dec. 1 each year since 1988, the Forum of International Respiratory Societies (FIRS) is calling on governments, health advocates and non-government organizations to strengthen their response to HIV/AIDS. In 2015 AIDS claimed 1.1 million lives.

30 Nov 2016

WHO releases new guidelines on self-testing to improve uptake of HIV diagnosis

In advance of World AIDS Day, the World Health Organization (WHO) has released new guidelines on HIV self-testing to improve access to and uptake of HIV diagnosis.

30 Nov 2016

Okayama University researchers find way to prevent replication of influenza viral RNA

Researchers at Okayama University have successfully cleaved influenza viral RNA to prevent its replication using novel artificial RNA restriction enzymes in laboratory cell cultures.

30 Nov 2016

ECDC: 1 in 7 HIV-infected people in the EU/EEA unaware of disease status

With 29 747 newly reported HIV infections in 2015, the EU/EEA notification rate is similar to recent years with an overall insignificant change from 6.6 per 100 000 population in 2006 to 6.3 in 2015 (adjusted for reporting delay).

29 Nov 2016

Researchers find new way to target deadly virus and develop vaccines

Venezuelan equine encephalitis virus (VEEV) is an unforgiving killer of horses, donkeys and zebras, resulting in mortality as high as 80 percent of infected animals. It causes rapid, catastrophic swelling of the brain and spinal cord, leading to severe neurological symptoms and--in many cases--sudden death.

29 Nov 2016

NIH-supported first HIV vaccine efficacy study begins in South Africa

The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults.

28 Nov 2016

Organic chemists develop method for rapid formation of optically active α-aminocarbonyl therapeutics

A team of organic chemists at ITbM, Nagoya University, has developed a new reaction to directly install amines into carbonyl compounds using their unique phase-transfer catalyst.

24 Nov 2016

Scientists develop new technology that sheds light on HIV infection

A group of researchers at the Centre for Genomic Regulation and the Pompeu Fabra University in Barcelona, Spain, have developed a new technology that sheds light on the HIV infection and offers a first glance at the expression landscape of the HIV in the human genome.

23 Nov 2016

HIV 1 News and Research

Surveys reveal exceptional progress against HIV in Africa

Special article outlines recommended strategies to prevent Zika from blood transfusion

Researcher to study ethical complexities of involving teens at high risk for HIV in prevention trials

New UGA research finds pathogen's motility activates immune response

‘Nudges’ could be effective way for encouraging patients to complete health care programs

New device could revolutionize drug delivery to treat cancer and other diseases, study shows

Liverpool-led research consortium aims to reduce mother-to-child transmission of HIV

FIRS calls on governments, health organizations to strengthen response to HIV on World AIDS Day

WHO releases new guidelines on self-testing to improve uptake of HIV diagnosis

Okayama University researchers find way to prevent replication of influenza viral RNA

ECDC: 1 in 7 HIV-infected people in the EU/EEA unaware of disease status

Researchers find new way to target deadly virus and develop vaccines

NIH-supported first HIV vaccine efficacy study begins in South Africa

Organic chemists develop method for rapid formation of optically active α-aminocarbonyl therapeutics

Scientists develop new technology that sheds light on HIV infection

FASEB announces winners of 2016 BioArt competition

New antiretroviral treatments show potential to reduce chances of sexual transmission of HIV virus

Researchers make significant progress in developing frontline protection against HIV infection

Scientists uncover novel process by which APOL1 gene contributes to renal disease

Scientists develop genetically engineered T cells with fusion inhibitor to disrupt HIV's harpoon

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News